Publication Information

{'id': 'https://openalex.org/W3164066485', 'doi': 'https://doi.org/10.1038/s42003-021-02750-6', 'title': 'Phosphorylation-dependent BRD4 dimerization and implications for therapeutic inhibition of BET family proteins', 'display_name': 'Phosphorylation-dependent BRD4 dimerization and implications for therapeutic inhibition of BET family proteins', 'publication_year': 2021, 'publication_date': '2021-11-09', 'ids': {'openalex': 'https://openalex.org/W3164066485', 'doi': 'https://doi.org/10.1038/s42003-021-02750-6', 'mag': '3164066485', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/34754068', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/8578508'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1038/s42003-021-02750-6', 'pdf_url': 'https://www.nature.com/articles/s42003-021-02750-6.pdf', 'source': {'id': 'https://openalex.org/S4210225776', 'display_name': 'Communications Biology', 'issn_l': '2399-3642', 'issn': ['2399-3642'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319908', 'host_organization_name': 'Nature Portfolio', 'host_organization_lineage': ['https://openalex.org/P4310319908', 'https://openalex.org/P4310319965'], 'host_organization_lineage_names': ['Nature Portfolio', 'Springer Nature'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'gold', 'oa_url': 'https://www.nature.com/articles/s42003-021-02750-6.pdf', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5043121037', 'display_name': 'Francesca Malvezzi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Francesca Malvezzi', 'raw_affiliation_strings': ['Structure, Biophysics and Fragment-Based Lead Generation, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK'], 'affiliations': [{'raw_affiliation_string': 'Structure, Biophysics and Fragment-Based Lead Generation, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5075703346', 'display_name': 'Christopher J. Stubbs', 'orcid': 'https://orcid.org/0000-0002-2373-5478'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Christopher J. Stubbs', 'raw_affiliation_strings': ['Structure, Biophysics and Fragment-Based Lead Generation, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK'], 'affiliations': [{'raw_affiliation_string': 'Structure, Biophysics and Fragment-Based Lead Generation, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5047090367', 'display_name': 'Thomas A. Jowitt', 'orcid': 'https://orcid.org/0000-0002-4045-0933'}, 'institutions': [{'id': 'https://openalex.org/I28407311', 'display_name': 'University of Manchester', 'ror': 'https://ror.org/027m9bs27', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I28407311']}, {'id': 'https://openalex.org/I2800776015', 'display_name': 'Wellcome Centre for Cell-Matrix Research', 'ror': 'https://ror.org/0094tm228', 'country_code': 'GB', 'type': 'facility', 'lineage': ['https://openalex.org/I2800776015', 'https://openalex.org/I28407311', 'https://openalex.org/I87048295']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Thomas A. Jowitt', 'raw_affiliation_strings': ['Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, UK'], 'affiliations': [{'raw_affiliation_string': 'Wellcome Trust Centre for Cell-Matrix Research, University of Manchester, Manchester, UK', 'institution_ids': ['https://openalex.org/I28407311', 'https://openalex.org/I2800776015']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5091801648', 'display_name': 'Ian L. Dale', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Ian L. Dale', 'raw_affiliation_strings': ['Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK'], 'affiliations': [{'raw_affiliation_string': 'Discovery Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK', 'institution_ids': ['https://openalex.org/I105036370']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5026336210', 'display_name': 'Xieyang Guo', 'orcid': 'https://orcid.org/0000-0002-0688-8464'}, 'institutions': [{'id': 'https://openalex.org/I4210143795', 'display_name': 'AstraZeneca (Sweden)', 'ror': 'https://ror.org/04wwrrg31', 'country_code': 'SE', 'type': 'company', 'lineage': ['https://openalex.org/I105036370', 'https://openalex.org/I4210143795']}], 'countries': ['SE'], 'is_corresponding': False, 'raw_author_name': 'Xieyang Guo', 'raw_affiliation_strings': ['Structure, Biophysics and Fragment-Based Lead Generation, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden'], 'affiliations': [{'raw_affiliation_string': 'Structure, Biophysics and Fragment-Based Lead Generation, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden', 'institution_ids': ['https://openalex.org/I4210143795']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5025963458', 'display_name': 'Jon P. DeGnore', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210150756', 'display_name': 'AstraZeneca (United States)', 'ror': 'https://ror.org/043cec594', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I105036370', 'https://openalex.org/I4210150756']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jon P. DeGnore', 'raw_affiliation_strings': ['Mechanistic Biology & Profiling, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Boston, USA'], 'affiliations': [{'raw_affiliation_string': 'Mechanistic Biology & Profiling, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Boston, USA', 'institution_ids': ['https://openalex.org/I4210150756']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5066982851', 'display_name': 'Gianluca Degliesposti', 'orcid': 'https://orcid.org/0000-0001-6387-2533'}, 'institutions': [{'id': 'https://openalex.org/I170203145', 'display_name': 'MRC Laboratory of Molecular Biology', 'ror': 'https://ror.org/00tw3jy02', 'country_code': 'GB', 'type': 'facility', 'lineage': ['https://openalex.org/I170203145', 'https://openalex.org/I4210087105', 'https://openalex.org/I90344618']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Gianluca Degliesposti', 'raw_affiliation_strings': ['Biological Mass Spectrometry and Proteomics, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge, UK'], 'affiliations': [{'raw_affiliation_string': 'Biological Mass Spectrometry and Proteomics, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge, UK', 'institution_ids': ['https://openalex.org/I170203145']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5021334033', 'display_name': 'Mark Skehel', 'orcid': 'https://orcid.org/0000-0002-2432-0901'}, 'institutions': [{'id': 'https://openalex.org/I170203145', 'display_name': 'MRC Laboratory of Molecular Biology', 'ror': 'https://ror.org/00tw3jy02', 'country_code': 'GB', 'type': 'facility', 'lineage': ['https://openalex.org/I170203145', 'https://openalex.org/I4210087105', 'https://openalex.org/I90344618']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'J. Mark Skehel', 'raw_affiliation_strings': ['Biological Mass Spectrometry and Proteomics, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge, UK'], 'affiliations': [{'raw_affiliation_string': 'Biological Mass Spectrometry and Proteomics, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge, UK', 'institution_ids': ['https://openalex.org/I170203145']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5070670737', 'display_name': 'Andrew J. Bannister', 'orcid': 'https://orcid.org/0000-0002-6312-4436'}, 'institutions': [{'id': 'https://openalex.org/I2801782436', 'display_name': 'Wellcome/Cancer Research UK Gurdon Institute', 'ror': 'https://ror.org/00fp3ce15', 'country_code': 'GB', 'type': 'facility', 'lineage': ['https://openalex.org/I241749', 'https://openalex.org/I2801316944', 'https://openalex.org/I2801782436', 'https://openalex.org/I87048295']}, {'id': 'https://openalex.org/I241749', 'display_name': 'University of Cambridge', 'ror': 'https://ror.org/013meh722', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I241749']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Andrew J. Bannister', 'raw_affiliation_strings': ['The Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, UK'], 'affiliations': [{'raw_affiliation_string': 'The Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge, UK', 'institution_ids': ['https://openalex.org/I2801782436', 'https://openalex.org/I241749']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5053772232', 'display_name': 'M. McAlister', 'orcid': 'https://orcid.org/0000-0003-3986-1767'}, 'institutions': [{'id': 'https://openalex.org/I105036370', 'display_name': 'AstraZeneca (United Kingdom)', 'ror': 'https://ror.org/04r9x1a08', 'country_code': 'GB', 'type': 'company', 'lineage': ['https://openalex.org/I105036370']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Mark S. McAlister', 'raw_affiliation_strings': ['Structure, Biophysics and Fragment-Based Lead Generation, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK'], 'affiliations': [{'raw_affiliation_string': 'Structure, Biophysics and Fragment-Based Lead Generation, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK', 'institution_ids': ['https://openalex.org/I105036370']}]}], 'institution_assertions': [], 'countries_distinct_count': 3, 'institutions_distinct_count': 8, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 2680, 'currency': 'EUR', 'value_usd': 2890, 'provenance': 'doaj'}, 'apc_paid': {'value': 2680, 'currency': 'EUR', 'value_usd': 2890, 'provenance': 'doaj'}, 'fwci': 1.116, 'has_fulltext': False, 'cited_by_count': 14, 'citation_normalized_percentile': {'value': 0.999981, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 90, 'max': 91}, 'biblio': {'volume': '4', 'issue': '1', 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12534', 'display_name': 'Protein Degradation and Inhibitors', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12534', 'display_name': 'Protein Degradation and Inhibitors', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11041', 'display_name': 'Ubiquitin and proteasome pathways', 'score': 0.9962, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10649', 'display_name': 'Multiple Myeloma Research and Treatments', 'score': 0.9959, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/brd4', 'display_name': 'BRD4', 'score': 0.9710562}, {'id': 'https://openalex.org/keywords/intrinsically-disordered-proteins', 'display_name': 'Intrinsically Disordered Proteins', 'score': 0.4752695}, {'id': 'https://openalex.org/keywords/casein-kinase-2', 'display_name': 'Casein kinase 2', 'score': 0.4400909}, {'id': 'https://openalex.org/keywords/transcription', 'display_name': 'Transcription', 'score': 0.42362988}], 'concepts': [{'id': 'https://openalex.org/C2779634854', 'wikidata': 'https://www.wikidata.org/wiki/Q18037206', 'display_name': 'BRD4', 'level': 5, 'score': 0.9710562}, {'id': 'https://openalex.org/C74401373', 'wikidata': 'https://www.wikidata.org/wiki/Q1829843', 'display_name': 'Bromodomain', 'level': 4, 'score': 0.88849276}, {'id': 'https://openalex.org/C11960822', 'wikidata': 'https://www.wikidata.org/wiki/Q242736', 'display_name': 'Phosphorylation', 'level': 2, 'score': 0.70483077}, {'id': 'https://openalex.org/C83640560', 'wikidata': 'https://www.wikidata.org/wiki/Q180951', 'display_name': 'Chromatin', 'level': 3, 'score': 0.64358395}, {'id': 'https://openalex.org/C41091548', 'wikidata': 'https://www.wikidata.org/wiki/Q26939', 'display_name': 'Epigenetics', 'level': 3, 'score': 0.53386647}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.49293876}, {'id': 'https://openalex.org/C86339819', 'wikidata': 'https://www.wikidata.org/wiki/Q407384', 'display_name': 'Transcription factor', 'level': 3, 'score': 0.4918506}, {'id': 'https://openalex.org/C64927066', 'wikidata': 'https://www.wikidata.org/wiki/Q36293', 'display_name': 'Histone', 'level': 3, 'score': 0.47565597}, {'id': 'https://openalex.org/C2778815515', 'wikidata': 'https://www.wikidata.org/wiki/Q3408242', 'display_name': 'Intrinsically disordered proteins', 'level': 2, 'score': 0.4752695}, {'id': 'https://openalex.org/C119157956', 'wikidata': 'https://www.wikidata.org/wiki/Q796604', 'display_name': 'Acetylation', 'level': 3, 'score': 0.44050476}, {'id': 'https://openalex.org/C143910341', 'wikidata': 'https://www.wikidata.org/wiki/Q21102140', 'display_name': 'Casein kinase 2', 'level': 5, 'score': 0.4400909}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.43249872}, {'id': 'https://openalex.org/C179926584', 'wikidata': 'https://www.wikidata.org/wiki/Q207714', 'display_name': 'Transcription (linguistics)', 'level': 2, 'score': 0.42362988}, {'id': 'https://openalex.org/C184235292', 'wikidata': 'https://www.wikidata.org/wiki/Q421851', 'display_name': 'Kinase', 'level': 2, 'score': 0.41534367}, {'id': 'https://openalex.org/C70721500', 'wikidata': 'https://www.wikidata.org/wiki/Q177005', 'display_name': 'Computational biology', 'level': 1, 'score': 0.37346894}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.35959297}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.33602095}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.2982915}, {'id': 'https://openalex.org/C97029542', 'wikidata': 'https://www.wikidata.org/wiki/Q281417', 'display_name': 'Protein kinase A', 'level': 3, 'score': 0.2255935}, {'id': 'https://openalex.org/C82495950', 'wikidata': 'https://www.wikidata.org/wiki/Q14911732', 'display_name': 'Cyclin-dependent kinase 2', 'level': 4, 'score': 0.1485303}, {'id': 'https://openalex.org/C41895202', 'wikidata': 'https://www.wikidata.org/wiki/Q8162', 'display_name': 'Linguistics', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C138885662', 'wikidata': 'https://www.wikidata.org/wiki/Q5891', 'display_name': 'Philosophy', 'level': 0, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D018797', 'descriptor_name': 'Cell Cycle Proteins', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': True}, {'descriptor_ui': 'D014157', 'descriptor_name': 'Transcription Factors', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': True}, {'descriptor_ui': 'D047390', 'descriptor_name': 'Casein Kinase II', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D005786', 'descriptor_name': 'Gene Expression Regulation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010766', 'descriptor_name': 'Phosphorylation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 3, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1038/s42003-021-02750-6', 'pdf_url': 'https://www.nature.com/articles/s42003-021-02750-6.pdf', 'source': {'id': 'https://openalex.org/S4210225776', 'display_name': 'Communications Biology', 'issn_l': '2399-3642', 'issn': ['2399-3642'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319908', 'host_organization_name': 'Nature Portfolio', 'host_organization_lineage': ['https://openalex.org/P4310319908', 'https://openalex.org/P4310319965'], 'host_organization_lineage_names': ['Nature Portfolio', 'Springer Nature'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578508', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/34754068', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1038/s42003-021-02750-6', 'pdf_url': 'https://www.nature.com/articles/s42003-021-02750-6.pdf', 'source': {'id': 'https://openalex.org/S4210225776', 'display_name': 'Communications Biology', 'issn_l': '2399-3642', 'issn': ['2399-3642'], 'is_oa': True, 'is_in_doaj': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319908', 'host_organization_name': 'Nature Portfolio', 'host_organization_lineage': ['https://openalex.org/P4310319908', 'https://openalex.org/P4310319965'], 'host_organization_lineage_names': ['Nature Portfolio', 'Springer Nature'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.86, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [{'funder': 'https://openalex.org/F4320307770', 'funder_display_name': 'AstraZeneca', 'award_id': None}], 'datasets': [], 'versions': [], 'referenced_works_count': 45, 'referenced_works': ['https://openalex.org/W1966227037', 'https://openalex.org/W1972370748', 'https://openalex.org/W1973462980', 'https://openalex.org/W1975317507', 'https://openalex.org/W1976033223', 'https://openalex.org/W1990174038', 'https://openalex.org/W1992127633', 'https://openalex.org/W1992387879', 'https://openalex.org/W1993172112', 'https://openalex.org/W2000596495', 'https://openalex.org/W2003872705', 'https://openalex.org/W2009949436', 'https://openalex.org/W2018971124', 'https://openalex.org/W2027974246', 'https://openalex.org/W2041535798', 'https://openalex.org/W2043517534', 'https://openalex.org/W2051959262', 'https://openalex.org/W2052535168', 'https://openalex.org/W2057460011', 'https://openalex.org/W2057519700', 'https://openalex.org/W2058405696', 'https://openalex.org/W2087087669', 'https://openalex.org/W2106836163', 'https://openalex.org/W2108958484', 'https://openalex.org/W2120572492', 'https://openalex.org/W2123647733', 'https://openalex.org/W2125358782', 'https://openalex.org/W2129129812', 'https://openalex.org/W2158076143', 'https://openalex.org/W2167732604', 'https://openalex.org/W2226721679', 'https://openalex.org/W2281722953', 'https://openalex.org/W2481128014', 'https://openalex.org/W2514318120', 'https://openalex.org/W2516657620', 'https://openalex.org/W2534491056', 'https://openalex.org/W2534743002', 'https://openalex.org/W2560661592', 'https://openalex.org/W2767131352', 'https://openalex.org/W2797814625', 'https://openalex.org/W2809057270', 'https://openalex.org/W2884966176', 'https://openalex.org/W3001038414', 'https://openalex.org/W3010650772', 'https://openalex.org/W3011089475'], 'related_works': ['https://openalex.org/W4362490146', 'https://openalex.org/W4237573852', 'https://openalex.org/W3088183071', 'https://openalex.org/W3021366882', 'https://openalex.org/W2916627146', 'https://openalex.org/W2797801723', 'https://openalex.org/W2346501107', 'https://openalex.org/W2227431445', 'https://openalex.org/W2032365395', 'https://openalex.org/W1909477846'], 'abstract_inverted_index': {'Abstract': [0], 'Bromodomain-containing': [1], 'protein': [2], '4': [3], '(BRD4)': [4], 'is': [5, 33, 39], 'an': [6], 'epigenetic': [7], 'reader': [8], 'and': [9, 38, 85, 121, 145], 'oncology': [10], 'drug': [11, 45], 'target': [12], 'that': [13, 67, 109], 'regulates': [14, 30], 'gene': [15], 'transcription': [16, 37], 'through': [17], 'binding': [18], 'to': [19, 43], 'acetylated': [20], 'chromatin': [21], 'via': [22], 'bromodomains.': [23], 'Phosphorylation': [24], 'by': [25, 69], 'casein': [26], 'kinase': [27], 'II': [28], '(CK2)': [29], 'BRD4': [31, 44, 59, 95, 117, 134], 'function,': [32], 'necessary': [34], 'for': [35, 93, 133, 137, 146], 'active': [36], 'involved': [40], 'in': [41, 47, 119, 122], 'resistance': [42], 'inhibition': [46], 'triple-negative': [48], 'breast': [49], 'cancer.': [50], 'Here,': [51], 'we': [52, 65, 99, 107], 'provide': [53], 'the': [54, 72, 86, 94, 101, 128, 138, 147], 'first': [55], 'biophysical': [56], 'analysis': [57], 'of': [58, 74, 130, 140, 149], 'phospho-regulation.': [60], 'Using': [61], 'integrative': [62], 'structural': [63, 96], 'biology,': [64], 'show': [66], 'phosphorylation': [68], 'CK2': [70], 'modulates': [71], 'dimerization': [73, 103], 'human': [75], 'BRD4.': [76], 'We': [77], 'identify': [78], 'two': [79], 'conserved': [80], 'regions,': [81], 'a': [82, 113, 131], 'coiled-coil': [83], 'motif': [84], 'Basic-residue': [87], 'enriched': [88], 'Interaction': [89], 'Domain': [90], '(BID),': [91], 'essential': [92], 'rearrangement,': [97], 'which': [98], 'term': [100], 'phosphorylation-dependent': [102], 'domain': [104], '(PDD).': [105], 'Finally,': [106], 'demonstrate': [108], 'bivalent': [110], 'inhibitors': [111], 'induce': [112], 'conformational': [114], 'change': [115], 'within': [116], 'dimers': [118], 'vitro': [120], 'cancer': [123], 'cells.': [124], 'Our': [125], 'results': [126], 'enable': [127], 'proposal': [129], 'model': [132], 'activation': [135], 'critical': [136], 'characterization': [139], 'its': [141], 'protein-protein': [142], 'interaction': [143], 'network': [144], 'development': [148], 'more': [150], 'specific': [151], 'therapeutics.': [152]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3164066485', 'counts_by_year': [{'year': 2024, 'cited_by_count': 3}, {'year': 2023, 'cited_by_count': 2}, {'year': 2022, 'cited_by_count': 8}, {'year': 2021, 'cited_by_count': 1}], 'updated_date': '2024-12-16T01:07:47.303151', 'created_date': '2021-06-07'}